This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "BrUOG 354 Trial Final Results - Nivo vs. Nivo/Ipi for Ovarian & Other Extra-Renal Clear Cell Carcinomas"

200 views
June 13, 2024

Chapters

BrUOG 354 Trial Overview & Objectives

00:00

Rationale for Immunotherapy in Clear Cell Cancers

03:29

BrUOG 354 Trial Design & Demographics

05:04

Treatment Results & Patient Case Study

08:28

Survivability Data & Final Conclusions

11:21

Comments 0
Login to view comments. Click here to Login